| Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis AV Langford, D Gnjidic, CWC Lin, L Bero, J Penm, FM Blyth, ... BMJ quality & safety 30 (2), 133-140, 2021 | 49 | 2021 |
| Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations AV Langford, CCW Lin, L Bero, FM Blyth, J Doctor, S Holliday, YH Jeon, ... Medical Journal of Australia 219 (2), 80-89, 2023 | 26 | 2023 |
| “The lesser of two evils”: a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines AV Langford, D Gnjidic, CWC Lin, L Bero, F Blyth, J Penm, CR Schneider Pain 162 (11), 2686-2692, 2021 | 20 | 2021 |
| Achieving sustainable healthcare through deprescribing D Gnjidic, M Johansson, DM Meng, B Farrell, A Langford, E Reeve Cochrane Database of Systematic Reviews, 2022 | 17 | 2022 |
| Patient‐targeted interventions for opioid deprescribing: An overview of systematic reviews AV Langford, CR Schneider, CWC Lin, L Bero, JC Collins, B Suckling, ... Basic & Clinical Pharmacology & Toxicology 133 (6), 623-639, 2023 | 12 | 2023 |
| The development of an Australian evidence-based clinical practice guideline for Deprescribing opioid analgesics A Langford | 12 | 2023 |
| Tools to evaluate medication management for caregivers of people living with dementia: a systematic review M Gench, MJ Sawan, A Langford, D Gnjidic Health Expectations 24 (5), 1570-1581, 2021 | 11 | 2021 |
| Measuring the impact of system level strategies on psychotropic medicine use in aged care facilities: A scoping review AV Langford, TF Chen, C Roberts, CR Schneider Research in Social and Administrative Pharmacy 16 (6), 746-759, 2020 | 11 | 2020 |
| Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021; 30 (2): 133–40 AV Langford, D Gnjidic, CWC Lin, L Bero, J Penm, FM Blyth, ... | 8 | |
| What do clinical practice guidelines say about deprescribing? A scoping review AV Langford, I Warriach, AM McEvoy, E Karaim, S Chand, JP Turner, ... BMJ Quality & Safety 34 (1), 28-39, 2025 | 7 | 2025 |
| Nurses’, pharmacists’ and family physicians’ perceptions of psychotropic medication monitoring in Australian long-term care facilities: a qualitative framework analysis AV Langford, GT Ngo, TF Chen, C Roberts, CR Schneider Drugs & Aging 38, 169-179, 2021 | 5 | 2021 |
| Deprescribing interventions in older adults: An overview of systematic reviews S Chua, A Todd, E Reeve, SM Smith, J Fox, Z Elsisi, S Hughes, ... PloS one 19 (6), e0305215, 2024 | 4 | 2024 |
| Survey content validation evaluating the dissemination and implementation of deprescribing guidelines CHJ Cheng, AV Langford, D Gnjidic, BJ Farrell, CR Schneider Basic & Clinical Pharmacology & Toxicology 134 (1), 63-71, 2024 | 3 | 2024 |
| Effectiveness of strategies for implementing guideline-concordant care in low back pain: a systematic review and meta-analysis of randomised controlled trials S Zhao, AV Langford, Q Chen, M Lyu, Z Yang, SD French, CM Williams, ... EClinicalMedicine 78, 2024 | 2 | 2024 |
| How is postoperative pain after hip and knee replacement managed? An analysis of two large hospitals in Australia GE Ferreira, AE Patanwala, H Turton, AV Langford, IA Harris, CG Maher, ... Perioperative Medicine 13 (1), 49, 2024 | 2 | 2024 |
| Opioids for Acute Musculoskeletal Pain: A Systematic Review with Meta-Analysis CMP Jones, A Langford, CG Maher, C Abdel Shaheed, R Day, CWC Lin Drugs 84 (3), 305-317, 2024 | 2 | 2024 |
| Government Direct-to-Consumer Education to Reduce Prescription Opioid Use: A Cluster Randomized Clinical Trial JP Turner, AS Halme, P Caetano, A Langford, C Tannenbaum JAMA Network Open 7 (5), e2413698-e2413698, 2024 | 1 | 2024 |
| Comment on:“Patient perceptions of opioids and benzodiazepines and attitudes toward deprescribing” AV Langford, CR Schneider, E Reeve, JN Doctor, D Gnjidic Drugs & Aging 41 (1), 77-78, 2024 | 1 | 2024 |
| Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care AV Langford, L Bero, CWC Lin, FM Blyth, JN Doctor, S Holliday, YH Jeon, ... Journal of Clinical Epidemiology 165, 111204, 2024 | 1 | 2024 |
| Characteristics and language of Deprescribing recommendations in clinical practice guidelines: A Scoping review A Langford OSF, 2023 | 1 | 2023 |